Presentation is loading. Please wait.

Presentation is loading. Please wait.

Plasma cotinine concentration over the weeks of the study during progressive reduction of the nicotine content of cigarettes (weeks 1–6) and after returning.

Published byИннокентий Шахматов Modified over 5 years ago

Similar presentations

Presentation on theme: "Plasma cotinine concentration over the weeks of the study during progressive reduction of the nicotine content of cigarettes (weeks 1–6) and after returning."— Presentation transcript:

1 Plasma cotinine concentration over the weeks of the study during progressive reduction of the nicotine content of cigarettes (weeks 1–6) and after returning to usual cigarettes or quitting (weeks 7–10).19 The bars represent the SEM. Data points represent mean values for 20 subjects. Plasma cotinine concentration over the weeks of the study during progressive reduction of the nicotine content of cigarettes (weeks 1–6) and after returning to usual cigarettes or quitting (weeks 7–10).19 The bars represent the SEM. Data points represent mean values for 20 subjects. Neal L Benowitz, and Jack E Henningfield Tob Control 2013;22:i14-i17 ©2013 by BMJ Publishing Group Ltd

Download ppt "Plasma cotinine concentration over the weeks of the study during progressive reduction of the nicotine content of cigarettes (weeks 1–6) and after returning."

Similar presentations

WEEK 1 You have 10 seconds to name…

WEEK 1 You have 10 seconds to name…
Date of download: 6/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Second-Hand Smoke and Gender on Infarct.

Date of download: 6/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Second-Hand Smoke and Gender on Infarct.
Self-titration by experienced e- cigarette users: Blood nicotine delivery and subjective effects Lynne Dawkins (LSBU), Catherine Kimber (UEL), Mira Doig.

Self-titration by experienced e- cigarette users: Blood nicotine delivery and subjective effects Lynne Dawkins (LSBU), Catherine Kimber (UEL), Mira Doig.
Figure 1. Estimated marginal mean (+/− SE) QSU-B factor 1 craving scores for the three-way interaction of Quitting Intention by Expect by Administered.

Figure 1. Estimated marginal mean (+/− SE) QSU-B factor 1 craving scores for the three-way interaction of Quitting Intention by Expect by Administered.
Figure 4. Sensitivity of illustrative simulated cumulative US deaths to cigarettes per day (CPD) reduction and to Excess Risk transition rates. See text.

Figure 4. Sensitivity of illustrative simulated cumulative US deaths to cigarettes per day (CPD) reduction and to Excess Risk transition rates. See text.
Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)

Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)
Immune function in cigarette smokers who quit smoking for 31 days

Immune function in cigarette smokers who quit smoking for 31 days
Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study Am J Nephrol 2016;43:366-374.

Metabolomics of Chronic Kidney Disease Progression: A Case-Control Analysis in the Chronic Renal Insufficiency Cohort Study Am J Nephrol 2016;43:
Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight change. Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight.

Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight change. Key clinical efficacy outcomes for (A) hemoglobin A1c (HbA1c), (B) weight.
 Correlation between plasma total antioxidant capacity of plasma (TAC) and protein SH groups (SH) (A), total hydroperoxide concentration (TH) and TAC (B),

 Correlation between plasma total antioxidant capacity of plasma (TAC) and protein SH groups (SH) (A), total hydroperoxide concentration (TH) and TAC (B),
Box plot of subarachnoid space measurements at each gestational week of age. Box plot of subarachnoid space measurements at each gestational week of age.

Box plot of subarachnoid space measurements at each gestational week of age. Box plot of subarachnoid space measurements at each gestational week of age.
Box plot of head circumference measurements at each gestational week of age. Box plot of head circumference measurements at each gestational week of age.

Box plot of head circumference measurements at each gestational week of age. Box plot of head circumference measurements at each gestational week of age.
Concentration-response curves for topsmelt (Atherinops affinis).

Concentration-response curves for topsmelt (Atherinops affinis).
Total weekly normal working hours in categories 1 (open bars: the department is open for its full repertoire of services with staff working their weekly.

Total weekly normal working hours in categories 1 (open bars: the department is open for its full repertoire of services with staff working their weekly.
Scanning Electron Microscope (SEM) images of the dialysis membranes: cross-section (a) 6 kDa, no polyvinylpyrrolidone (PVP); (b) 12 kDa, 2% PVP; (c) 16 kDa,

Scanning Electron Microscope (SEM) images of the dialysis membranes: cross-section (a) 6 kDa, no polyvinylpyrrolidone (PVP); (b) 12 kDa, 2% PVP; (c) 16 kDa,
Relative cancer potencies of formaldehyde and acetaldehyde in vapour from e-cigarettes compared with tobacco smoke, heat-not-burn devices, a nicotine inhaler.

Relative cancer potencies of formaldehyde and acetaldehyde in vapour from e-cigarettes compared with tobacco smoke, heat-not-burn devices, a nicotine inhaler.
Masashi Maeda et al. Heart Asia 2013;5:7-14

Masashi Maeda et al. Heart Asia 2013;5:7-14
Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.

Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.
Percentage of smokers making a quit attempt, for smokers of all ethnicities and non-Hispanic white smokers. Percentage of smokers making a quit attempt,

Percentage of smokers making a quit attempt, for smokers of all ethnicities and non-Hispanic white smokers. Percentage of smokers making a quit attempt,
Status of premarket submissions to FDA (data source: U. S

Status of premarket submissions to FDA (data source: U. S

Similar presentations

Ads by Google